Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


New Amedeo service:

Amedeo COVID-19 (formerly 2019-nCoV)

Weekly publication summary


  Prostate Cancer

  Free Subscription


13.01.2020

1 AJR Am J Roentgenol
1 Am J Surg Pathol
2 Anticancer Res
3 BJU Int
1 BMC Cancer
1 Br J Radiol
2 Cancer
1 Cancer Res
3 Clin Cancer Res
1 Endocrinology
1 Eur Urol
1 Hum Pathol
1 Int J Oncol
1 Int J Radiat Oncol Biol Phys
1 Int J Urol
1 J Clin Oncol
2 J Urol
1 Magn Reson Imaging
2 Magn Reson Med
1 PLoS One
7 Prostate
13 Urology


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AJR Am J Roentgenol

  1. KIM SH
    Development and External Validation of Multiparametric MRI-Derived Nomogram to Predict Risk of Pathologic Upgrade in Patients on Active Surveillance for Prostate Cancer.
    AJR Am J Roentgenol. 2020 Jan 8:1-10. doi: 10.2214/AJR.19.22196.
    PubMed     Text format     Abstract available


    Am J Surg Pathol

  2. IREMASHVILI V, Pelaez L, Jorda M, Parekh DJ, et al
    A Comprehensive Analysis of the Association Between Gleason Score at a Positive Surgical Margin and the Risk of Biochemical Recurrence After Radical Prostatectomy.
    Am J Surg Pathol. 2019;43:369-373.
    PubMed     Text format     Abstract available


    Anticancer Res

  3. SHIOTA M, Nakamura M, Yokomizo A, Tomoda T, et al
    Prognostic Impact of Prior Androgen Receptor Axis-targeting Agents in Cabazitaxel Chemotherapy After Docetaxel.
    Anticancer Res. 2020;40:335-339.
    PubMed     Text format     Abstract available

  4. ABBAS M, Mason T, Ibad A, Khraiwesh M, et al
    Genetic Polymorphisms in IL-10 Promoter Are Associated With Smoking and Prostate Cancer Risk in African Americans.
    Anticancer Res. 2020;40:27-34.
    PubMed     Text format     Abstract available


    BJU Int

  5. LOVEGROVE CE, Musbahi O, Ranasinha N, Omer A, et al
    Implications of celebrity endorsement of prostate cancer awareness in a tertiary referral unit- The "Fry-Turnbull" Effect.
    BJU Int. 2020 Jan 7. doi: 10.1111/bju.14992.
    PubMed     Text format     Abstract available

  6. JAMBOR I, Falagario U
    Does prostate magnetic resonance imaging (MRI) reporting system affect performance of MRI in men with a clinical suspicion of prostate cancer?
    BJU Int. 2020;125:4-5.
    PubMed     Text format    

  7. ROBBINS R, Jean-Louis G, Chanko N, Combs P, et al
    Using data from an online health community to examine the impact of prostate cancer on sleep.
    BJU Int. 2020 Jan 3. doi: 10.1111/bju.14986.
    PubMed     Text format     Abstract available


    BMC Cancer

  8. LIAO KM, Huang YB, Chen CY, Kuo CC, et al
    Risk of ischemic stroke in patients with prostate cancer receiving androgen deprivation therapy in Taiwan.
    BMC Cancer. 2019;19:1263.
    PubMed     Text format     Abstract available


    Br J Radiol

  9. KIM E, Kim CK, Kim HS, Jang DP, et al
    Histogram analysis from stretched exponential model on diffusion-weighted imaging: evaluation of clinically significant prostate cancer.
    Br J Radiol. 2020 Jan 9:20190757. doi: 10.1259/bjr.20190757.
    PubMed     Text format     Abstract available


    Cancer

  10. HUYNH-LE MP, Myklebust TA, Feng CH, Karunamuni R, et al
    Age dependence of modern clinical risk groups for localized prostate cancer-A population-based study.
    Cancer. 2020 Jan 3. doi: 10.1002/cncr.32702.
    PubMed     Text format     Abstract available

  11. MAHAL BA, Alshalalfa M, Zhao SG, Beltran H, et al
    Genomic and clinical characterization of stromal infiltration markers in prostate cancer.
    Cancer. 2020 Jan 6. doi: 10.1002/cncr.32688.
    PubMed     Text format     Abstract available


    Cancer Res

  12. SAHA S, Kiran M, Kuscu C, Chatrath A, et al
    Long noncoding RNA DRAIC inhibits prostate cancer progression by interacting with IKK to inhibit NF-kappaB activation.
    Cancer Res. 2020 Jan 3. pii: 0008-5472.CAN-19-3460.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  13. NOURI M, Massah S, Caradec J, Lubik AA, et al
    Transient Sox9 Expression Facilitates Progression to Castrate Resistant Prostate Cancer.
    Clin Cancer Res. 2020 Jan 9. pii: 1078-0432.CCR-19-0098.
    PubMed     Text format     Abstract available

  14. SCHWEIZER MT, Yu EY
    "Matching" the "mismatch" repair deficient prostate cancer with immunotherapy.
    Clin Cancer Res. 2020 Jan 3. pii: 1078-0432.CCR-19-3780.
    PubMed     Text format     Abstract available

  15. SHANKAR S, Ganapathy S, Srivastava RK
    Editor's Note: Sulforaphane Enhances the Therapeutic Potential of TRAIL in Prostate Cancer Orthotopic Model through Regulation of Apoptosis, Metastasis, and Angiogenesis.
    Clin Cancer Res. 2020;26:312.
    PubMed     Text format    


    Endocrinology

  16. PARK S, Song CS, Lin CL, Jiang S, et al
    Inhibitory Interplay of SULT2B1b Sulfotransferase with AKR1C3 Aldo-keto Reductase in Prostate Cancer.
    Endocrinology. 2020 Jan 2. pii: 5693375. doi: 10.1210.
    PubMed     Text format     Abstract available


    Eur Urol

  17. TOSOIAN JJ, Mamawala M, Epstein JI, Landis P, et al
    Active Surveillance of Grade Group 1 Prostate Cancer: Long-term Outcomes from a Large Prospective Cohort.
    Eur Urol. 2020 Jan 6. pii: S0302-2838(19)30961.
    PubMed     Text format     Abstract available


    Hum Pathol

  18. KRYVENKO ON, Williamson SR, Schwartz LE, Epstein JI, et al
    Gleason score 5+3=8 (grade group 4) prostate cancer - a rare occurrence with contemporary grading.
    Hum Pathol. 2020 Jan 7. pii: S0046-8177(19)30207.
    PubMed     Text format     Abstract available


    Int J Oncol

  19. LU Z, Wu C, Zhu M, Song W, et al
    Ophiopogonin D' induces RIPK1dependent necroptosis in androgendependent LNCaP prostate cancer cells.
    Int J Oncol. 2019 Dec 17. doi: 10.3892/ijo.2019.4945.
    PubMed     Text format     Abstract available


    Int J Radiat Oncol Biol Phys

  20. HAWKEN SR, Spratt DE, Qi J, Linsell SM, et al
    Utilization of Salvage Radiation Therapy for Biochemical Recurrence After Radical Prostatectomy.
    Int J Radiat Oncol Biol Phys. 2019;104:1030-1034.
    PubMed     Text format     Abstract available


    Int J Urol

  21. UKIMURA O
    Editorial Comment from Dr Ukimura to Magnetic resonance imaging/transrectal ultrasonography fusion targeted prostate biopsy finds more significant prostate cancer in biopsy-naive Japanese men compared with the standard biopsy.
    Int J Urol. 2020 Jan 8. doi: 10.1111/iju.14168.
    PubMed     Text format    


    J Clin Oncol

  22. NOSSITER J, Sujenthiran A, Cowling TE, Parry MG, et al
    Patient-Reported Functional Outcomes After Hypofractionated or Conventionally Fractionated Radiation for Prostate Cancer: A National Cohort Study in England.
    J Clin Oncol. 2020 Jan 2:JCO1901538. doi: 10.1200/JCO.19.01538.
    PubMed     Text format     Abstract available


    J Urol

  23. CARLSSON S, Benfante N, Alvim R, Sjoberg DD, et al
    Risk of Metastasis in Men with Grade Group 2 Prostate Cancer Managed with Active Surveillance at a Tertiary Cancer Center.
    J Urol. 2020 Jan 7:101097JU0000000000000742. doi: 10.1097/JU.0000000000000742.
    PubMed     Text format     Abstract available

  24. LEONG DP, Fradet V, Shayegan B, Duceppe E, et al
    Cardiovascular Risk in Men with Prostate Cancer: Insights from the RADICAL PC Study.
    J Urol. 2020 Jan 3:101097JU0000000000000714. doi: 10.1097/JU.0000000000000714.
    PubMed     Text format     Abstract available


    Magn Reson Imaging

  25. GIGANTI F, Pecoraro M, Fierro D, Campa R, et al
    DWI and PRECISE criteria in men on active surveillance for prostate cancer: A multicentre preliminary experience of different ADC calculations.
    Magn Reson Imaging. 2019;67:50-58.
    PubMed     Text format     Abstract available


    Magn Reson Med

  26. CHAN RW, Lau AZ, Detzler G, Thayalasuthan V, et al
    Evaluating the accuracy of multicomponent T2 parameters for luminal water imaging of the prostate with acceleration using inner-volume 3D GRASE.
    Magn Reson Med. 2019;81:466-476.
    PubMed     Text format     Abstract available

  27. ZHANG Y, Wells SA, Hernando D
    Stimulated echo based mapping (STEM) of T1 , T2 , and apparent diffusion coefficient: validation and protocol optimization.
    Magn Reson Med. 2019;81:167-181.
    PubMed     Text format     Abstract available


    PLoS One

  28. BOUTTELL J, Teoh J, Chiu PK, Chan KS, et al
    Economic evaluation of the introduction of the Prostate Health Index as a rule-out test to avoid unnecessary biopsies in men with prostate specific antigen levels of 4-10 in Hong Kong.
    PLoS One. 2019;14:e0215279.
    PubMed     Text format     Abstract available


    Prostate

  29. ROGERS O, Yen H, Solomon A, Drake C, et al
    An IL-2 proaerolysin fusion toxin that selectively eliminates regulatory t cells to enhance antitumor immune response.
    Prostate. 2019;79:1071-1078.
    PubMed     Text format     Abstract available

  30. SONG Q, Qin S, Pascal LE, Zou C, et al
    SIRPB1 promotes prostate cancer cell proliferation via Akt activation.
    Prostate. 2020 Jan 6. doi: 10.1002/pros.23950.
    PubMed     Text format     Abstract available

  31. HAWLEY JE, Pan S, Figg WD, Lopez-Bujanda ZA, et al
    Association between immunosuppressive cytokines and PSA progression in biochemically recurrent prostate cancer treated with intermittent hormonal therapy.
    Prostate. 2020 Jan 3. doi: 10.1002/pros.23948.
    PubMed     Text format     Abstract available

  32. BANDO Y, Hinata N, Terakawa T, Furukawa J, et al
    Diagnostic and therapeutic value of pelvic lymph node dissection in the fossa of Marcille in patients with clinically localized high-risk prostate cancer: Histopathological and molecular analyses.
    Prostate. 2020 Jan 3. doi: 10.1002/pros.23949.
    PubMed     Text format     Abstract available

  33. SHIOTA M, Ushijima M, Imada K, Kashiwagi E, et al
    Cigarette smoking augments androgen receptor activity and promotes resistance to antiandrogen therapy.
    Prostate. 2019;79:1147-1155.
    PubMed     Text format     Abstract available

  34. KATO M, Hirakawa A, Kobayashi Y Ms, Yamamoto A, et al
    The influence of the presence of intraductal carcinoma of the prostate on the grade group system's prognostic performance.
    Prostate. 2019;79:1065-1070.
    PubMed     Text format     Abstract available

  35. YU H, Shi Z, Wu Y, Wang CH, et al
    Concept and benchmarks for assessing narrow-sense validity of genetic risk score values.
    Prostate. 2019;79:1099-1105.
    PubMed     Text format     Abstract available


    Urology

  36. LAM JS
    Editorial Comment.
    Urology. 2019;133:185.
    PubMed     Text format    

  37. MOON SK, You MW, Lim JW
    Granulomatous Prostatitis Mimicking Prostate Cancer.
    Urology. 2019 Dec 30. pii: S0090-4295(19)31136.
    PubMed     Text format     Abstract available

  38. LOPES VENDRAMI C, McCarthy RJ, Chatterjee A, Casalino D, et al
    The Utility of Prostate Specific Antigen Density, Prostate Health Index, and Prostate Health Index Density in Predicting Positive Prostate Biopsy Outcome is Dependent on the Prostate Biopsy Methods.
    Urology. 2019;129:153-159.
    PubMed     Text format     Abstract available

  39. WANGERIN K, Iagaru A
    (68)Ga Scatter Correction to Eliminate Halo-Artifacts in PET Imaging.
    Urology. 2019;131:262.
    PubMed     Text format    

  40. LEPOR H
    EDITORIAL COMMENT.
    Urology. 2019;133:179.
    PubMed     Text format    

  41. REICHARD CA, Chapin BF
    Editorial Comment.
    Urology. 2019;131:174.
    PubMed     Text format    

  42. ANSCHER MS
    EDITORIAL COMMENT.
    Urology. 2019;131:164-165.
    PubMed     Text format    

  43. SAMMON JD, Trinh QD
    EDITORIAL COMMENT.
    Urology. 2019;130:84-85.
    PubMed     Text format    

  44. UNWALA DJ
    Editorial Comment.
    Urology. 2019;130:104-105.
    PubMed     Text format    

  45. SINGLA N, Margulis V
    EDITORIAL COMMENT.
    Urology. 2019;129:85.
    PubMed     Text format    

  46. HEIDENREICH A, Rieke M
    Editorial Comment.
    Urology. 2019;129:163.
    PubMed     Text format    

  47. GUPTA I, Freid B, Masarapu V, Machado P, et al
    Transrectal Subharmonic Ultrasound Imaging for Prostate Cancer Detection.
    Urology. 2019 Dec 30. pii: S0090-4295(19)31132.
    PubMed     Text format     Abstract available

  48. STRAND D
    EDITORIAL COMMENT.
    Urology. 2019;129:163-164.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Prostate Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: